Cyclophilin A: a novel biomarker for cardiovascular disease in patients with type 2 diabetes

• Hauptverfasser: Manal M Hussain (Verfasst von), Emad A.M. Abdel Hady Mohammed (Verfasst von), Alyaa A El-Sherbeny (Verfasst von), Amira R Shehata (Verfasst von)
• Format: Buch
• Veröffentlicht: SpringerOpen, 2019-01-01T00:00:00Z.
• Schlagworte: article
• Online-Zugang: Connect to this object online.

Background and aims Type 2 diabetes mellitus (DM) is a strong independent risk factor for coronary heart disease. Cyclophilin A (CyPA) is a protein secreted from vascular smooth muscle cells in response to reactive oxygen species. It is suggested that CyPA plays an important role in later stages of...